ADVANCED NSCLC

Clinical trials for ADVANCED NSCLC explained in plain language.

Never miss a new study

Get alerted when new ADVANCED NSCLC trials appear

Sign up with your email to follow new studies for ADVANCED NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Completed 1 Terminated 1

Scientists map genetic clues after key lung cancer drug fails

Knowledge-focused Completed

This study aimed to understand why a common first-line lung cancer drug (osimertinib) stops working for some patients. Researchers analyzed genetic material from 182 patients with advanced lung cancer after their disease progressed on this drug. By comparing tissue and blood samp…

Matched conditions: ADVANCED NSCLC

Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Knowledge-focused

Last updated Mar 27, 2026 12:41 UTC

ADVANCED NSCLC

Get alerted when new ADVANCED NSCLC trials appear

Scientists map genetic clues after key lung cancer drug fails